Trial Profile
A phase I of JZP-258 (Sodium-oxybate) in healthy adult volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Nov 2023
Price :
$35
*
At a glance
- Drugs JZP 258 (Primary)
- Indications Catalepsy; Narcolepsy
- Focus Adverse reactions
- 12 Sep 2023 Results characterizing PK and relative bioavailability in Japanese vs non-Asian healthy participants presented at the 2023 American College of Clinical Pharmacology Annual Meeting
- 17 Mar 2017 New trial record